Boston Scientific Corporation (BSX) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2020 | $-B | $-B | - | - | - |
| FY2021 | $11.89B | $1.82B | $0.69 | 93.9% | 63.25 |
| FY2022 | $12.68B | $2.03B | $0.45 | 84.8% | 103.33 |
| FY2023 | $14.24B | $2.42B | $1.07 | 79.9% | 54.36 |
| FY2024 | $16.75B | $3.00B | $1.25 | 79.0% | 72.55 |